EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Extracellular Vesicles as Mediators of Pathophysiology and Disease Progression in Cardiovascular Diseases

Melina Tangos, Luca Schneider iD, Oliver Jarkas iD, Ibrahim El-Battrawy, Nazha Hamdani iD

International Journal of Molecular Sciences · 29.07.2026 · 27 (15) · 6786

DOI: 10.3390/ijms27156786 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 29.07.2026. Verfasst von Melina Tangos und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cellular and Translational Physiology, Institute of Physiology, Medical Faculty, Ruhr University Bochum, 44801 Bochum, Germany. Hauptthemen laut MEDLINE: Extracellular Vesicles, Cardiovascular Diseases. Die Arbeit nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union's Horizon 2020 research and innovation program, Ruhr University Bochum, Innovation Forum program of the Medical Faculty, European Union’s Horizon 2020 research and innovation program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The rising prevalence of cardiovascular diseases (CVDs) worldwide imposes a substantial economic burden on healthcare systems. Despite major advances in evidence-based therapies and modern healthcare, the demand for novel, time- and cost-effective treatment options continues to grow. Extracellular vesicles (EVs), including apoptotic bodies, microvesicles, and exosomes, are released by numerous cell types and mediate intercellular communication in both physiological and pathological contexts. To date, researchers have amassed compelling evidence for the functional roles of EVs in the development and progression of myocardial disease, supporting their exploration for clinical applications. In this review, we examine the multifunctional roles of EVs from diverse cellular origins in prominent CVD manifestations, highlighting publications of the last eight years and their key findings. They confirm that EVs carry disease-specific molecular cargo, particularly microRNAs, long non-coding RNAs, proteins, and other bioactive molecules, contributing to inflammation, oxidative stress, fibrosis, endothelial dysfunction, and cardiac remodeling, while also serving as promising diagnostic and prognostic biomarkers. Furthermore, emerging preclinical evidence demonstrates the therapeutic potential of engineered or tissue-derived EVs for promoting cardiac repair and limiting adverse cardiac remodeling.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Extracellular VesiclesCardiovascular DiseasesHumansAnimalsDisease ProgressionBiomarkersCell CommunicationMicroRNAs

Stichwörter der Autor:innen

biomarker discoverycardiovascular diseasescell communicationextracellular vesicles

Substanzen

BiomarkersMicroRNAs

Autor:innen und Institutionen

  • Department of Cellular and Translational Physiology, Institute of Physiology, Medical Faculty, Ruhr University Bochum, 44801 Bochum, Germany.
  • Department of Cardiology and Rhythmology, St. Josef-Hospital, Ruhr University Bochum, 44801 Bochum, Germany.
  • Department of Physiology, Cardiovascular Research Institute Maastricht, University Maastricht, 6200 MD Maastricht, The Netherlands.

ORCID-Profile: Luca Schneider, Oliver Jarkas, Nazha Hamdani

Förderung

  • European Union's Horizon 2020 research and innovation program
  • Ruhr University Bochum, Innovation Forum program of the Medical Faculty
  • European Union’s Horizon 2020 research and innovation program
  • Innovation Forum program of the Medical Faculty

Zitieren

APA

Tangos, M., Schneider, L., Jarkas, O., El-Battrawy, I., & Hamdani, N. (2026). Extracellular Vesicles as Mediators of Pathophysiology and Disease Progression in Cardiovascular Diseases. International Journal of Molecular Sciences, 27(15), 6786. https://doi.org/10.3390/ijms27156786

Vancouver

Tangos M, Schneider L, Jarkas O, El-Battrawy I, Hamdani N. Extracellular Vesicles as Mediators of Pathophysiology and Disease Progression in Cardiovascular Diseases. International Journal of Molecular Sciences. 2026;27(15):6786. doi:10.3390/ijms27156786

BibTeX
@article{Tangos2026,
  author = {Tangos, Melina and Schneider, Luca and Jarkas, Oliver and El-Battrawy, Ibrahim and Hamdani, Nazha},
  title = {Extracellular Vesicles as Mediators of Pathophysiology and Disease Progression in Cardiovascular Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {15},
  pages = {6786},
  doi = {10.3390/ijms27156786}
}
Kostenlos starten →